MicroGen DX

Sound familiar? A chronic infection. Repeatedly misdiagnosed.

Steve had been dealing with an infection whose cause was missed again and again, until he learned about MensKEY testing.

With MensKEY's broad detective power, he finally got clear, detailed results that impressed his healthcare provider.

DNA-level testing identifies the microbial cause with species-level precision, enabling treatment.
If you've been told nothing is wrong but something clearly is, there's a better data-driven way to find out.

🔗 Learn more about MensKEY: https://loom.ly/H0SeuuU

Last Saturday, MicroGenDX's Lubbock team ran for the I Am Enough 5K, supporting women's well-being, health, and community.

Women's health matters to our people, both in the lab and beyond it.

Events like these remind us that community and validation are just as vital to women's health as the answers we work to deliver each day.

Thank you to everyone who showed up 💙

Hip and knee surgeons:
Still using the Big Ortho PJI panel?

Mayo Clinic published in 2021 (Ivy et al., Bone Joint J, PMID 34058872): the alpha-defensin biomarker in that panel is no more accurate than the synovial WBC and PMN% your lab already runs.

Two peer-reviewed figures:

→ ~$3,916 = published cost-effectiveness ceiling (Torchia 2019)

→ ~$400 = OrthoKEY published price (Tipton 2026, n=2,011)

OrthoKEY sits ~90% below the ceiling and delivers:

✓ Pathogen identification (bacterial + fungal)

✓ Resistance gene profile

✓ Same biomarkers as the Big Ortho panel

✓ Polymicrobial detection

✓ Result in as little as 24 to 48 hours

Learn more → https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1816780/full